Application no. and date | 12781489.5 (espacenet) (Federated) (European Patent Register), 20121001 | Patent/reg. no. and date | DK/EP 2750683, 20180321 | Publication date | 20140709 | Priority no. and date | US 201161542425 P, 20111003 | EP pub. no. and date |
EP 2750683 20140709 | Effective date | | Applicant/owner | CRODA INTERNATIONAL PLC, Cowick Hall Snaith
Goole East Yorkshire DN14 9AA, GB | Applicant ref. no. | LUPV1435604/EP-DK-APO | Inventor | Morein, Bror, Ollonstigen 3
S-755 91 Uppsala, SE, Berenjian, Saideh, Kontrabasvägen 3
S-756 54 Uppsala, SE, Hu, Kefei, Cellovägen 26
S-756 54 Uppsala, SE | Representative | Dennemeyer & Associates S.A, P.O. Box 700425
DE-81304 Munich, DE | Opponent | | IPC Class | A61K 31/015 (2006.01) , A61K 36/00 (2006.01) | Title | NANOPARTIKLER, FREMGANGSMÅDE TIL FREMSTILLING OG ANVENDELSE
DERAF SOM BÆRER FOR AMFIPATISKE ELLER HYDROFOBE MOLEKYLER
INDEN FOR MEDICIN, HERUNDER CANCERBEHANDLING, OG I
FØDEVARERELATEREDE FORBINDELSER | Int. application no. | SE2012051048 | Int. publication no. | WO2013051994 | Related patent (certificate) | | Status | Ændret DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|